Introduction {#sec1}
============

*Acinetobacter baumannii* is an important cause of nosocomial infection in intensive care units (ICUs) and is often resistant to multiple antibiotics [@bib1], [@bib2], [@bib3]. Integrons are partly responsible for the multiantibiotic resistance of *A*. *baumannii*. Integrons are genetic elements that can integrate, by site-specific recombination, antibiotic-resistant gene cassettes [@bib4]. Five main types of integrons have been described based the basis of the sequence of the encoded 5′ integrases (40--58% identity), including class I (Tn402 derivatives), class II (Tn7 derivatives), class III (located in a transposon), class IV (a subset of conjugative transposon in *Vibrio cholerae*) and class V (located in a compound transposon carried on a plasmid in *Vibrio salmonicida*) [@bib5], [@bib6]. All the integrons have a 5′ conserved segment, including an *intI* gene encoding an integrase and an *attI* recombination site, but have distinct 3′ conserved segments. Gene cassettes from class I integrons confer resistance to all known β-lactams, all aminoglycosides, chloramphenicol, trimethoprim, streptothricin, rifampin, erythromycin, fosfomycin, lincomycin and antiseptics of the quaternary--ammonium compound family [@bib7], while fewer resistance cassettes (*dfrA1, sat1, sat2, aadB, bla*~CARB-4~, *aadA1*) have been found that were associated with class II integrons [@bib8]. In China, integrons containing drug-resistant cassettes were considered to be a major resistant element [@bib9], [@bib10], with an integron detection ratio ranging from 52.3% to 69.6%.

Similar to reports from other hospitals in China, *A. baumannii* and its colonization have greatly increased at the Second Affiliated Hospital of Chongqing Medical University during the last several years. The mechanism by which it is doing this needs to be investigated. The aim of this study was to explore the roles, characteristics and frequency of integrons in *A. baumannii* drug resistance development at our hospital.

Materials and Methods {#sec2}
=====================

Isolates, antimicrobial agents susceptibility testing and data analysis {#sec2.1}
-----------------------------------------------------------------------

Between January 2011 and December 2011, a total of 189 nonrepetitive clinical isolates of *Acinetobacter baumannii* were collected from the laboratory of the Second Affiliated Hospital of Chongqing Medical University. *A. baumannii* multidrug-resistant isolates are resistant to more than two of the following five drug classes: penicillins (piperacillin, ampicillin/sulbactam or ticarcillin/clavulanic acid), cephalosporins (cefepime, ceftriaxone, cefotaxime or ceftazidime), carbapenems (imipenem), trimethoprim/sulfame--thoxazole, fluoroquinolones (ciprofloxacin, levofloxacin or gatifloxacin), and aminoglycosides (gentamicin, tobramycin or amikacin) [@bib11]. Minimum inhibitory concentrations were determined by bioMérieux Vitek 2 AST-GN 13 cards (<http://www.biomerieux-diagnostics.com/vitek-2-ast-cards>) or MicroScan Dried Gram Negative Combo 31 panels (<https://www.beckmancoulter.com/wsrportal/WSR/diagnostics/clinical-products/microbiology/microscan-panels/index.htm>) with the relevant instruments. Our routine quality control method was in accordance with the manufacturer\'s guidelines. The breakpoints of various antibiotics to *A. baumannii* followed Clinical and Laboratory Standards Institute guidelines. The susceptibility differences among *A. baumannii* strains were analysed by the WHONET 5.6 program (World Health Organization; <http://www.who.int/drugresistance/whonetsoftware/en/>). The chi-square test was used to determine the significance of differences. A difference was considered statistically significant if the p value was less than 0.05.

Integron detection {#sec2.2}
------------------

Primers for class I, II and III integrons identification are listed in [Table 1](#tbl1){ref-type="table"}. PCR amplification parameters have been reported previously [@bib12]. One or two cassette amplicons representative of each size were selected for DNA sequence characterization. The resulting DNA sequences were analysed by the BLAST program (<http://www.ncbi.nlm.nih.gov/BLAST/>).

Molecular typing and multilocus sequence typing (MLST) analysis of ICU strains {#sec2.3}
------------------------------------------------------------------------------

For the 33 strains from patients in the ICU, repetitive PCR testing (rep-PCR) was carried out to analyse the endemic group and additional sporadic isolates [@bib15]. MLST analyses were performed to characterize the epidemic features of ICU-isolated strains [@bib16]. The c scheme and protocols are publicly available online (<http://www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html>).

Results {#sec3}
=======

Antimicrobial susceptibility testing {#sec3.1}
------------------------------------

The proportion of isolates resistant to tested antimicrobial agents included piperacillin (92.7%), ampicillin/sulbactam (84.5%), ticarcillin/clavulanic acid (80.4%), ceftazidime (88.7%), ceftriaxone (90.2%), cefotaxime (92.2%), cefepime (93.8%), imipenem (72.2%), amikacin (78.8%), gentamicin (81.4%), tobramycin (76.8%), ciprofloxacin (89.7%), gatifloxacin (62.6%), levofloxacin (67%) and trimethoprim/sulfame--thoxazole (81.4%). The majority (93.3%) of the isolates in this study were multidrug resistant (resistant to more than two categories of antibiotic), which was higher than the reported ratio [@bib17], and 38.7% of the isolates were resistant to all antibiotics used in our test.

Integron assessment of *A. baumannii* isolates {#sec3.2}
----------------------------------------------

Integrons were widely distributed among clinically isolated *A. baumannii* strains in this teaching hospital in Chongqing, China. Among the 189 isolates analysed by PCR, 144 isolates (76.2%) were found to have the integron cassette; it was absent in the rest. Among the integron-positive isolates, 136 had a class I integron cassette and eight had a class II integron cassette. We did not detect class III integrons in isolates from this hospital.

Mapping of integrons {#sec3.3}
--------------------

The cassette assortments in all the strains were characterized by sequencing the amplification products ([Table 2](#tbl2){ref-type="table"}). Among the 128 class I integron-carrying isolates, five different types of gene cassettes in segments of approximately 1.3, 1.6, 2, 2.5 and 3.1 kb between the 5′ conserved segment and the 3′ conserved segment regions were amplified by PCR. The five types of class I integron cassettes included: *aad*A2-HP-*dfr*A, *aac*C1-ORF1-ORF2-*aad*A1, *arr*-3-*aac*A4, *dfrA*17-*aad*A5 and *aad*B-*cat*-*blaOXA10*-*aad*A1. The cassettes of *aad*A2-HP-*dfr*A accounted for 83.9% of all integron-positive cassettes, making it was the most prevalent type in the integron-carrying *A. baumannii* isolate. There were two types of class II cassettes, comprising type 4 fimbriae expression regulatory protein *pilR* and sulfate adenylyltransferase.

Correlation between integron and drug resistance {#sec3.4}
------------------------------------------------

We compared susceptibility data from integron-positive and -negative *A. baumannii* isolates ([Table 3](#tbl3){ref-type="table"}). The chi-square test was used to calculate the p value in terms of resistant and susceptible numbers of integron-positive and -negative isolates. Integron presence was significantly associated with resistance to certain antibiotics. The resistance ratio to amikacin, ampicillin/sulbactam, trimethoprim/sulfame--thoxazole, ciprofloxacin, gatifloxacin, piperacillin, gentamicin, ticarcillin/clavulanic acid, cefepime, ceftriaxone, cefotaxime, ceftazidime, tobramycin, imipenem and levofloxacin were detected in integron-positive *A. baumannii* strains than in integron-negative strains (p \< 0.01).

Molecular typing of ICU-isolated strains {#sec3.5}
----------------------------------------

Because the ICU environment is the hardest hit with *A. baumannii* infection, molecular typing using rep-PCR and MLST were carried out in strains isolated from the ICU. Rep-PCR testing of ICU isolates showed that 16 of 19 isolated were closely related, with similarity scores of over 80% ([Fig. 1](#fig1){ref-type="fig"}). We assumed that isolates with closely linked rep-PCR results would be the same MLST type, so only five representative strains were processed for MLST typing. All five strains were consistent with sequence type (ST) 2, corresponding to European clone II [@bib18].

Discussion {#sec4}
==========

Among the 189 clinical isolates in our study, resistance ratios to each tested antimicrobial agents were all above 60%. The susceptibility of clinical isolates to tobramycin (21.1%) and imipenem (26.8%) is more that 20%; only these two antimicrobial agents had a tolerable killing ability of clinical *A. baumannii* from this hospital. These data highlighted the severe challenge of drug-resistant *A. baumannii* nosocomial infection.

A total of 144 (76.2) of 189 strains were found to have an integron cassette, most of them belonging to a class I integron. The frequency of integron positivity in this hospital is higher than that in other countries and regions, such as 60% in the United Kingdom (*A. baumannii*) [@bib19], 50% in the Netherlands (*Enterobacteriaceae*) [@bib20], 59% in France (*Enterobacteriaceae*) [@bib21], 52% in Taiwan (*Escherichia coli*) [@bib22], 43% in Europe (Gram-negative isolates) [@bib12], 41.5% in Brazil (*Pseudomonas aeruginosa*) [@bib23] and 52.8% in Nanjing [@bib10] and 40.7% in Zhejiang, China [@bib24]. The class I integron-positive frequency (136/189, 72.0%) is similar to those in Guangzhou, China (74.9%), and Eastern China (69.6%) [@bib9], [@bib25].

AdaA2-HP-dfrA is the most prevalent integron cassette in our study. Recently a study in Southern China also revealed *dfr*XII-*orf*F-*aad*A2 to be the major integron cassette [@bib9]. DfrA is a dihydrofolate reductase mediating the drug resistance to trimethoprim, and AadA2 is a aminoglycoside adenyltransferase involved in drug resistance to aminoglycoside. This integron cassette has been reported in other regions of China, including Nanjing and Zhejiang [@bib10], [@bib24], but the ratio of this cassette in other regions is lower than our data. Other drug-resistant genes were also present in these integron cassettes, including *aacC*1, *aadA*1, *arr*3, *aacA*4, *dfrA*17 and *aadA*5; and *aad*B, *cat* and *blaOXA10* encoded resistance to aminoglycoside, rifampin, sulfanilamide, chloramphenicol and β-lactam, respectively. Most cassettes encoding various aminoglycoside resistance genes were consistent with previous studies [@bib22], [@bib26]. In addition, this study detected only two sulfanilamide resistance genes (*dfrA*12 and *dfrA*17) and one β-lactam resistance gene (*blaOXA10*) in *A. baumannii* integron, which seems insufficient to explain the significant correlations between integron positivity and these two types antimicrobial agents. Nearly all class I integrons characterized to date contain a 3′ conserved segment comprising a *sulI* resistance gene in addition to the *qacEΔ1* gene; both of them mediated sulfanilamide resistance [@bib27], and the β-lactam-resistant genes might locate outside of integrons or plasmids [@bib12]. Integron positivity was also strongly correlated with fluoroquinolone resistance, although no fluoroquinolone-resistant genes existed in the integron. A previous study reported a clear association of integron structures with mutator plasmids, such as R46, in many *Enterobacteriaceae* [@bib28], which can confer an increased baseline mutation rate in the host cell [@bib29] and lead to an increase in the frequency of point mutations that give rise to fluoroquinolone-resistant phenotypes.

*PilR* is a member of the two-component regulatory system *PilS/PilR* that regulates the expression of type 4 fimbriae, which was first reported in *Pseudomonas aeruginosa* [@bib30]. Type IV pili are essential for motility, biofilm formation, adherence to multiple surfaces and natural transformation and virulence [@bib31], [@bib32]. In general, the drug-resistant characters of class II integron-positive isolates and integron-negative isolates are not significantly different (except gatifloxacin; data not shown), so whether the two genes in the class II integrons are related to drug resistance needs further study.

Isolates from the ICU belonged to the ST2 genotype in this teaching hospital. The ST2 genotypic entity was also a predominated clonal lineage in multiple centers, such as Mediterranean countries [@bib33] and Germany [@bib34]. In addition, ICU-isolated strains also showed a relatively high carbapenem resistance (18 of 19 ICU isolates resistant to imipenem, for a resistance ratio of 95%; overall imipenem-resistant ratio is 71.1%), similar to that of ST2 strains isolated from other countries [@bib35], [@bib36].

Conclusion {#sec5}
==========

This study demonstrated the wide distribution of integrons among *A. baumannii* within the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. A distinct feature of our findings is the prevalence of the major class I integron consisting of *aad*A2-HP-*dfr*A resistance genes in this hospital. Two novel class II integron cassettes also are reported. Regardless of the presence or absence of resistance genes within an integron, our data demonstrated a significant association between the presence of integrons and a reduced susceptibility to many antibiotics.
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###### 

Primers for integron identification

  Integrase gene            Primer sequence                Reference
  ------------------------- ------------------------------ --------------------
  intl 1                    5′-GGCATCCAAGCAGCAAG-3′        [@bib12], [@bib13]
  5′-AAGCAGACTTGACCTGA-3′                                  
  intl 2                    5′-ACCTTTTTGTCGCATATCCGTG-3′   [@bib14]
                            5′-TACCTGTTCTGCCCGTATCT-3′     
  intl 3                    5′-GCCTCCGGCAGCGACTTTCAG-3′    [@bib14]
                            5′-ACGGATCTGCCAAACCTGACT-3′    

###### 

Integron cassette types and contents of *Acinetobacter baumannii* clinical isolates

  Integron type   Coding length   No. of isolates   Function annotation
  --------------- --------------- ----------------- -------------------------------------------------------
  Class I         1332            2                 Arr-3 and aacA4
  Class I         1606            2                 DfrA17-aadA5
  Class I         3124            2                 AadB-cat-blaOXA10-aadA1
  Class I         1998            135               AadA2-HP-dfrA
  Class I         2513            11                aacC1-ORF1-ORF2- aadA1
  Class II        480             5                 Type 4 fimbriae expression regulatory protein, *pilR*
  Class II        1480            4                 Sulfate adenylyltransferase

dfrA12, dihydrofolate reductase; HP, hypothetical protein (HP); aadA2, adenyltransferase; rifampin ADP-ribosylating transferase (arr-3) and aminoglycoside 6′-N-acetyltransferase (aacA4) genes, aminoglycoside 2′-O-adenylyltransferase (aadB), chloramphenicol acetyltransferase (cat), oxacillinase (bla~oxa-10~), and aminoglycoside 3′- (9)-O-adenylyltransferase (aadA1) genes.

###### 

Association between antibiotic profile and integrons in *Acinetobacter baumannii* strains

  Antibiotic   Antibiotic susceptibility   Integron-positive isolates   Integron-negative isolates   p                                         
  ------------ --------------------------- ---------------------------- ---------------------------- ------ ------ ------ ------ ------ ------ ---------
  AMK          78.6                        2.3                          19.1                         91     0.8    8.3    35.7   7.1    57.1   \<0.005
  SAM          84                          4.8                          11.2                         92.4   2.1    5.6    55.6   13.3   31.1   \<0.005
  SXT          81.3                        0                            18.7                         91     0      9      46.7   0      53.3   \<0.005
  CIP          89.3                        1.1                          9.6                          95.8   0      4.2    66.7   4.4    28.9   \<0.005
  GAT          61.8                        23.1                         15                           68.4   25.6   6      40.5   14.3   45.2   \<0.005
  PIP          92.5                        3.5                          4                            97.7   0.8    1.5    76.2   11.9   11.9   \<0.005
  GEN          81.3                        3.2                          15.5                         91     2.1    6.9    46.7   6.7    46.7   \<0.005
  TIM          79.8                        7.5                          12.7                         85.7   9      5.3    59.5   2.4    38.1   \<0.005
  FEP          93.6                        1.6                          4.8                          96.5   1.4    2.1    84.4   2.2    13.3   \<0.005
  CRO          89.8                        7.5                          12.7                         96.5   2.1    1.4    68.9   24.4   6.7    \<0.005
  CTX          91.9                        5.8                          2.3                          97     1.5    1.5    76.2   19     4.8    \<0.005
  CAZ          88.8                        2.7                          8.6                          95.8   0.7    3.5    66.7   8.9    24.4   \<0.005
  TOB          76.5                        2.1                          21.4                         86.8   1.4    11.8   40     4.4    55.6   \<0.005
  IPM          71.1                        1.1                          27.8                         75.7   0.7    23.6   55.6   2.2    42.2   \<0.01
  LVX          65.8                        20.9                         13.4                         68.1   25.7   6.2    45.7   10.4   43.9   \<0.005

%R, resistant rate; %I, intermediate rate; %S, sensitive rate; AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; FEP, cefepime; GAT, gatifloxacin; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; PIP, piperacillin; SAM, ampicillin/sulbactam; SXT, trimethoprim/sulfame--thoxazole; TIM, ticarcillin/clavulanic acid; TOB, tobramycin.
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